Iambic Therapeutics Announces Close of Oversubscribed $100 Million Series B Financing to Advance AI-Discovered Therapeutics into Clinical Development and Enters Collaboration with NVIDIABusiness Wire • 10/03/23
Did Microsoft Just Give a Big Hint That Nvidia's Remarkable Run Could Soon Be Over?The Motley Fool • 10/03/23
NVIDIA stock climbs as Goldman Sachs adds chipmaker to ‘conviction list'Proactive Investors • 10/02/23
Chipmaker Nvidia Called Principal 'Shovel Supplier' In AI 'Gold Rush'Investors Business Daily • 10/02/23
Magnificent Seven tech stocks haven't been this cheap in six years, Goldman Sachs strategists sayMarket Watch • 10/02/23
A quant fund boss talked his mom into selling Nvidia at 60% of its current price. She won't let him forget it.Business Insider • 10/02/23
Chip, Dip, and Rebound Whip: Why Nvidia's Lower Share Price Is a Buying OpportunityInvestorPlace • 09/30/23